International
Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-daily liraglutide when taken alone produced statistically significant improvement in blood sugar (glucose) control in patients with type 2 diabetes, as compared to glimepiride, a widely used oral anti-diabetic drug (OAD).
In addition, liraglutide demonstrated the following benefits compared to glimepiride:
-Statistically significant reduction in body weight
-Statistically significant reduction in risk of hypoglycemia
-Statistically significant reduction in systolic blood pressure
In this 12-month study, 62% of patients treated with liraglutide who had not been previously treated with diabetes medications achieved an average reduction in blood sugar that brought them below the ADA target for HbA1c of 7%.
To view Multimedia News release go to, http://www.prnewswire.com/mnr/novonordisk/33424/
Rated 1.77 | 211 Views
Rated 1.14 | 286 Views
Rated 4.41 | 192 Views
Blood Sugar Control from Diabetes Care Club
Rated 3.24 | 93 Views
Rated 0.00 | 91 Views
Rated 2.33 | 62 Views
Rated 0.00 | 84 Views
Rated 0.00 | 68 Views
Rated 0.00 | 57 Views
Rated 0.00 | 28 Views
Rated 0.00 | 37 Views
Rated 4.12 | 35 Views
Rated 0.00 | 79 Views
Landmark Study In The Lancet: Patients Tre...ated With Betaseron Af
Rated 2.38 | 237 Views
By MultiVu
Understanding Blood Sugar Levels.
Rated 3.26 | 806 Views
By taulandi
Rated 1.69 | 25 Views